344 related articles for article (PubMed ID: 29160908)
1. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.
Rayego-Mateos S; Morgado-Pascual JL; Rodrigues-Diez RR; Rodrigues-Diez R; Falke LL; Mezzano S; Ortiz A; Egido J; Goldschmeding R; Ruiz-Ortega M
J Pathol; 2018 Feb; 244(2):227-241. PubMed ID: 29160908
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor is a new ligand of epidermal growth factor receptor.
Rayego-Mateos S; Rodrigues-Díez R; Morgado-Pascual JL; Rodrigues Díez RR; Mas S; Lavoz C; Alique M; Pato J; Keri G; Ortiz A; Egido J; Ruiz-Ortega M
J Mol Cell Biol; 2013 Oct; 5(5):323-35. PubMed ID: 23929714
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.
Rodrigues-Diez RR; Garcia-Redondo AB; Orejudo M; Rodrigues-Diez R; Briones AM; Bosch-Panadero E; Kery G; Pato J; Ortiz A; Salaices M; Egido J; Ruiz-Ortega M
Antioxid Redox Signal; 2015 Jan; 22(1):29-47. PubMed ID: 25065408
[TBL] [Abstract][Full Text] [Related]
4. CCN2 Binds to Tubular Epithelial Cells in the Kidney.
Rayego-Mateos S; Morgado-Pascual JL; Lavoz C; Rodrigues-Díez RR; Márquez-Expósito L; Tejera-Muñoz A; Tejedor-Santamaría L; Rubio-Soto I; Marchant V; Ruiz-Ortega M
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204752
[TBL] [Abstract][Full Text] [Related]
5. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
6. Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage.
Rayego-Mateos S; Rodrigues-Diez R; Morgado-Pascual JL; Valentijn F; Valdivielso JM; Goldschmeding R; Ruiz-Ortega M
Mediators Inflamm; 2018; 2018():8739473. PubMed ID: 30670929
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Design of Novel Cyclic Peptides as Specific Inhibitors Targeting CCN2 and Disrupting CCN2/EGFR Interaction for Kidney Fibrosis Treatment.
Dong J; Xiao J; Li J; Yu H; Zhao Q; Tang Q; Chen H; Liu H; Wu K; Lei J; Wang R; Jiang X
J Med Chem; 2023 Jun; 66(12):8251-8266. PubMed ID: 37279405
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
[TBL] [Abstract][Full Text] [Related]
9. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
10. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
11. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.
Riquelme-Guzmán C; Contreras O; Brandan E
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C415-C427. PubMed ID: 29351412
[TBL] [Abstract][Full Text] [Related]
12. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.
Chung H; Ramachandran R; Hollenberg MD; Muruve DA
J Biol Chem; 2013 Dec; 288(52):37319-31. PubMed ID: 24253040
[TBL] [Abstract][Full Text] [Related]
14. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HER2 in tubular epithelial cell drives fibroblast activation and renal fibrosis.
Li H; Shao F; Qian B; Sun Y; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
Kidney Int; 2019 Sep; 96(3):674-688. PubMed ID: 31327474
[TBL] [Abstract][Full Text] [Related]
17. Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
Li R; Guo Y; Zhang Y; Zhang X; Zhu L; Yan T
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30836660
[TBL] [Abstract][Full Text] [Related]
18. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor induces tubular epithelial to mesenchymal transition through the activation of canonical Wnt signaling in vitro.
Yang Z; Sun L; Nie H; Liu H; Liu G; Guan G
Ren Fail; 2015 Feb; 37(1):129-35. PubMed ID: 25296105
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor-(CTGF, CCN2)--a marker, mediator and therapeutic target for renal fibrosis.
Phanish MK; Winn SK; Dockrell ME
Nephron Exp Nephrol; 2010; 114(3):e83-92. PubMed ID: 19955828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
